Early surfactant in spontaneously breathing with nCPAP in ELBW infants--a single centre four year experience

Acta Paediatrica
Angela KribsB Roth


To evaluate whether the experience with a method to administer surfactant during spontaneous breathing with nasal continuous positive airway pressure (nCPAP) as primary respiratory support in infants with respiratory distress syndrome (RDS) influences the frequency of its use and affects the outcome of patients. All inborn extremely low birthweight (ELBW) infants treated after introduction of the method were retrospectively studied (n=196). The entire observational period was divided into four periods (periods 1-4) and compared with a control period (period 0) (n=51). Primary respiratory support, demographics, prenatal risks and outcomes were compared. There were no changes in demographics or prenatal risks over time. The choice of nCPAP as initial airway management significantly increased from 69% to 91% and for nCPAP with surfactant from 75% to 86%. The rate of nCPAP failure decreased from 46% to 25%. Survival increased significantly between periods 0 and 1 from 76% to 90% and survival without bronchopulmonary dysplasia (BPD) rose from 65% to 80%. No changes in nonpulmonary outcomes were observed. The success of nCPAP increased with increasing use of nCPAP with surfactant. Simultaneously, mortality decreased without deteriora...Continue Reading


Sep 1, 1995·Pediatric Pulmonology·J AlbaI M Hiatt
Jan 25, 2000·Journal of Perinatology : Official Journal of the California Perinatal Association·R A QuinteroM Kruger
Feb 19, 2002·American Journal of Respiratory and Critical Care Medicine·Boris W KramerAlan H Jobe
Dec 5, 2002·Seminars in Neonatology : SN·Mohammad Ali Attar, Steven M Donn
Sep 3, 2004·Pediatrics·Neil N FinerUNKNOWN National Institute of Child Health and Human Development Neonatal Research Network
Jun 3, 2005·Pediatrics·Hany AlyAyman A E El-Mohandes
Sep 27, 2005·The Journal of Pediatrics·Amer AmmariRichard A Polin
Jul 6, 2006·Archives of Disease in Childhood. Fetal and Neonatal Edition·C BoothA D Edwards

❮ Previous
Next ❯


Aug 8, 2013·Therapeutic Delivery·Nashwa El-GendyPrajnaparamita Dhar
Nov 21, 2009·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Carlo DaniGiovanna Bertini
Jul 5, 2011·Paediatric Respiratory Reviews·Ramadan A MahmoudGerd Schmalisch
Jul 24, 2008·Acta Paediatrica·Ds Patel, A Greenough
Mar 21, 2012·Acta Paediatrica. Supplement·Kajsa Bohlin
Aug 19, 2015·Frontiers in Pediatrics·Theodora Katsila, George P Patrinos
Apr 8, 2015·Indian Pediatrics·M EibisbergerB Resch
Feb 13, 2013·Critical Care Research and Practice·Megan O'ReillyGeorg M Schmölzer
Oct 19, 2017·Korean journal of pediatrics·Gyu-Hong Shim
Apr 25, 2017·Clinical and Experimental Emergency Medicine·Dong Jin YangKyoung Soo Lim
Dec 13, 2016·European Journal of Pediatrics·Daniel KlotzHans Fuchs
Jan 13, 2019·Journal of Perinatology : Official Journal of the California Perinatal Association·Dalibor KurepaVenkatakrishna Kakkilaya
Jan 27, 2021·Early Human Development·Hemant AmbulkarAnne Greenough
May 11, 2021·The Cochrane Database of Systematic Reviews·Mohamed E Abdel-LatifPeter A Dargaville
May 25, 2021·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Yedidiel ElbazEric S Shinwell
Oct 3, 2021·NeoReviews·Scott O GuthrieKari D Roberts
Mar 21, 2012·Pediatrics·Gerhardus Francois KirstenJustin Harvey

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.